Sihuan Pharmaceutical Holdings
Sihuan Pharmaceutical Holdings Group Ltd, commonly referred to as Sihuan Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Beijing, China. Founded in 2001, the company has established itself as a leader in the development, manufacturing, and marketing of innovative pharmaceutical products, particularly in the fields of cardiovascular and central nervous system therapies. With a strong operational presence across major regions in China, Sihuan Pharmaceutical is renowned for its unique portfolio of prescription drugs and over-the-counter products. The company has achieved significant milestones, including the successful launch of several key medications that address critical health needs. Sihuan Pharmaceutical's commitment to research and development, coupled with its strategic market positioning, has garnered recognition within the industry, solidifying its reputation as a trusted provider of high-quality healthcare solutions.
DitchCarbon Score
How does Sihuan Pharmaceutical Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sihuan Pharmaceutical Holdings's score of 30 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sihuan Pharmaceutical Holdings's reported carbon emissions
In 2023, Sihuan Pharmaceutical Holdings, headquartered in China (CN), reported total carbon emissions of approximately 104,067,670 kg CO2e. This figure includes 45,601,810 kg CO2e from Scope 1 emissions and 58,465,860 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data for this year. Over the past few years, Sihuan Pharmaceutical has shown fluctuations in its emissions. In 2022, the total emissions were about 123,292,250 kg CO2e, with Scope 1 and Scope 2 emissions at 52,191,660 kg CO2e and 71,100,590 kg CO2e, respectively. In 2021, the total emissions were approximately 122,823,710 kg CO2e, with Scope 1 emissions of 49,323,750 kg CO2e and Scope 2 emissions of 73,499,960 kg CO2e. Despite these figures, Sihuan Pharmaceutical has not set specific reduction targets or disclosed any significant climate commitments, such as those aligned with the Science Based Targets initiative (SBTi). The absence of documented reduction initiatives suggests that the company may be in the early stages of developing a comprehensive climate strategy. Overall, while Sihuan Pharmaceutical Holdings has made strides in reporting its emissions, further commitments and reduction targets will be essential for enhancing its sustainability profile in the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 55,110,200 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 36,269,100 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 482,200 | 000,000,000 | 000,000,000 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sihuan Pharmaceutical Holdings is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
